Certain strains ofEscherichia coli frequently referred to as enterohemorrhagic E. coli (EHEC) (22) produce verotoxin 1 (VT1) and/or verotoxin 2 (VT2) (Shiga-like toxin I and/or II) and attach to and efface the microvilli from intestinal epithelium. These organisms have been incriminated as a cause of hemorrhagic or nonhemorrhagic colitis in humans and other animals (9, 17, 18) . In humans, they may also cause hemolytic uremic syndrome (8) and thrombotic thrombocytopenic purpura (26) . Verotoxins are believed to be virulence factors in these syndromes, but their role in disease remains un- clear. When applied to HeLa or Vero cells, the toxins are cytolytic (21, 27) , and VT1 administered parenterally to experimental animals caused necrosis of the endothelial and muscular layers of blood vessels (7a, 31) . However, in one experimental model, the toxins did not appear essential for the generation of diarrhea in these animals (39) .
Gnotobiotic pigs are very susceptible to experimental infection by EHEC and have been used by several investigators as a model for studying the pathogenesis of disease caused by these organisms (9, 12, 38, 40, 41) . When gnotobiotic pigs are inoculated with verotoxigenic E. coli (VTEC), they develop nonbloody diarrhea and, with certain strains, neurologic disease also occurs (10) . A description of the pathogenesis of acute illness has been the focus of the previously reported experimental challenge studies. In those studies, animals were observed for 5 days or less after inoculation. In contrast, we maintained gnotobiotic pigs for 3 to 4 weeks following inoculation with a serotype O111:NM VTEC strain, and these animals remained diarrheic throughout. Examination of diarrheic pigs revealed histologic evidence of chronic typhlocolitis and persistent infection of intestinal epithelium by the challenge organism.
Chronic infection caused by E. coli serotype O111:NM has also been previously reported (1, 7, 19, 33, 34) . Persistent diarrhea is a recognized clinical expression of entero-pathogenic E. coli (EPEC) infection in humans (23) . Clinical cases involving EHEC organisms in which patients had diarrhea that persisted up to 2 weeks (19) and was of a duration similar to that of the EPEC cases have been reported (7, 33) . However, the potential for various EPEC and EHEC strains to cause diarrhea for this length of time has not been investigated in the gnotobiotic pig model. We have identified an EHEC strain which has the capacity to cause chronic infection in gnotobiotic pigs and is of a serotype (O111:NM) associated with persistent diarrhea. The purpose of our study was to determine whether the chronic infection and colitis observed in gnotobiotic pigs inoculated with VTEC (O111:NM) might be associated with an immunocompromised condition.
MATERIALS AND METHODS
Animals. Gnotobiotic pigs were obtained by closed hysterotomy and maintained in rigid tub isolators similar to those previously described (25 RESULTS Clinical signs and postmortem examination. Surviving pigs inoculated with strain 10049 had persistent diarrhea and anorexia associated with chronic typhlocolitis. Twenty-three (85%) of 27 strain 10049-inoculated pigs had diarrhea which persisted until the pigs were euthanized at 3 to 4 weeks postinoculation. The other four pigs died 5 days after inoculation, before the onset of diarrhea. Of the strain 2430-inoculated pigs, seven (78%) of nine developed transient diarrhea, and three were anorexic for only a couple of days. Five (38%) of 13 of the uninoculated control pigs developed transient diarrhea, but none exhibited depression or anorexia.
Histopathologic examination of the large intestines of nine pigs inoculated with strain 10049 revealed attaching-effacing bacterial colonization of the luminal and crypt epithelial surfaces in seven (78%), loss of crypt epithelium and fibrosis in the mucosa or submucosa in six (67%), and neutrophilic inflammation of the mucosal surfaces, chronic inflammation of the laminae propriae and submucosae, and loss of lymphoglandular complexes in seven (78%). Histologic examination of the lymphoid tissues revealed atrophy of the periarterial lymphatic sheaths of the spleens in six (67%) of nine pigs. Two pigs lacking attaching-effacing lesions also did not demonstrate chronic colitis or lymphoid depletion of the lymphoglandular complexes and periarterial lymphatic sheaths. No histopathologic lesions were seen in pigs inoculated with strain 2430 (n = 11) or G58-1 (n = 16) or in the uninoculated controls (n = 8). (37) .
Total lymphocyte count. Changes in the distribution of leukocytes have been associated with reduced immune competence (2, 15) . Therefore, peripheral blood was examined for the total leukocyte count and the percentage of lymphocytes. Pigs inoculated with strain 10049 had a significantly decreased absolute mean lymphocyte count compared with that of uninoculated controls for weeks 1 to 4 postinoculation and that of strain 2430-inoculated pigs for weeks 2 to 4 postinoculation (Fig. 1) . The mean lymphocyte count for pigs inoculated with strain 10049 at 4 weeks of age only was significantly lower than that for pigs inoculated with strain G58-1 (P < 0.001) (data not shown).
Anti-SRBC titers. The antibody response to a complex antigen was determined in each treatment group via an anti-SRBC titer. The geometric mean anti-SRBC titer for pigs inoculated with strain 10049 was significantly lower than that for G58-1-inoculated pigs or uninoculated controls. A trend for a lower geometric mean titer was also observed in pigs inoculated with strain 10049 compared with those given strain 2430 (P = 0.07) (Fig. 2) . No significant differences were noted in antibody titers between uninoculated controls and pigs given strain 2430 (P = 0.12). Uninoculated controls and strain 2430-and 10049-inoculated pigs all had titers significantly lower than those of pigs inoculated with G58-1 (Fig. 2) .
Mitogen assays. Reduced functional activity of lympho- (in) and pigs inoculated with strain G58-1 (n = 15) (i), 10049 (n = 13) ( M ) or 2430 (n = 7) ( ) at 4 weeks postinoculation.
Significant differences (P c 0.05) from results for strain G58-1-inoculated pigs and for uninoculated controls are indicated by + and 0, respectively.
cytes was indicated by the results of mitogen assays, which indicated that lymphocytes from pigs inoculated with VTEC did not have the same potential to undergo clonal expansion as did those from control pigs or from pigs inoculated with verotoxin-negative E. coli (Fig. 3) . Concanavalin A, phytohemagglutinin, and pokeweed mitogens induced lymphocyte proliferation in pigs inoculated with strain 10049 that was significantly lower than the proliferation in pigs given strain 2430 or uninoculated pigs throughout the 4 weeks assayed. The mitogenic response to lipopolysaccharide for all treatment groups was too low for comparisons to be made. The capacity of B cells to undergo a proliferative response to lipopolysaccharide may not be well developed in 1-to 4-week-old gnotobiotic pigs. Therefore, it is difficult to make any definite comparisons of B-cell proliferation in response to lipopolysaccharide between these groups.
DISCUSSION
In this report, we provide evidence suggesting that persistent infection by E. coli serotype O111:NM (strain 10049) in gnotobiotic pigs may be due, at least in part, to the ability of the organism to compromise the immunoresponsive capacity of its host. Evidence for immunocompromise was found both in histologic changes in lymphoidal tissues and in immune function. These changes included severe depletion of periarterial lymphatic sheaths in the spleen, loss of lymphoglandular complexes in the submucosa of the large intestine, low numbers of lymphocytes in peripheral blood, lowered proliferative responses to T-cell mitogens, and decreased antibody production.
Decreased numbers of peripheral lymphocytes may be accounted for by their migration to lymphoid tissue (5) or possibly even lymphatic or vascular leakage as seen in chronic enteric disease (20) . Since atrophy of lymphoid tissue was observed on histologic examination, we could also suggest that destruction or decreased production of lymphocytes had occurred. Several studies have indicated that Shiga toxin (which is essentially identical to VT1) (16) number and behavior and account for both the lowered lymphocyte count and mitogenic responses seen in our study (6) . We also observed a significantly lower complement-fixing antibody response to SRBCs in pigs inoculated with VTEC than in controls. Since T-cell function was compromised in pigs inoculated with VTEC, as indicated by low mitogenic responses, the interaction of T-cell cytokines (e.g., interleukin 4, 5, or 6) with B cells may also have been affected and may have caused a decreased antibody response (32) . Pigs used as bacterial colonization controls (inoculated with strain G58-1) exhibited an increased capacity to produce anti-SRBC antibody compared with that of uninoculated controls. The interaction between the immune system and the G58-1 organism during the 4 weeks of the experiment appears to have promoted the development of the humoral response in these gnotobiotic pigs. This is consistent with our observations (unpublished observations) that gnotobiotic pigs compared with their conventionally raised counterparts have slower immunological development and are less responsive (13) .
The mechanism(s) by which strain 10049 compromises the immune system is not entirely clear. It is tempting to speculate that verotoxin is a contributing factor since the O111:NM verotoxin-negative strain 2430 did not persistently infect gnotobiotic pigs and had a much-less-pronounced suppressive effect (and, in fact, sometimes had a stimulatory effect) on immune function than did the verotoxin-positive strain 10049. Recently, the mechanism by which several organisms cause chronic or persistent infections has been attributed to the action of the cytotoxins which they produce and which are defined as superantigens (14) . Some, such as the staphylococcal enterotoxins, have been shown to suppress antibody production in vitro (35) and humoral and cellular immune responses in vivo (30 13, 6 , and 20 (week 1); 13, 6, and 15 (week 2); 11, 4, and 13 (week 3); and 3, 4, and 5 (week 4) for uninoculated pigs (i) and pigs inoculated with strain 2430 (10) or 10049 ( M ), respectively. Significant differences (P < 0.05) from results for uninoculated controls and for pigs inoculated with strain 2430 are indicated by + and *, respectively. (3) , and studies are in progress to so characterize VT1 (1Sa). However, since strain 10049 differs from strain 2430 in more than just the production of verotoxin (strain 10049 is an EHEC while strain 2430 is an EPEC), additional or other virulence factors may be responsible for the observed immunocompromise.
An 0157:H7, VT1-positive strain (strain 933D) (36) infects gnotobiotic pigs (10) but does not cause persistent diarrhea or chronic disease in gnotobiotic pigs (26a). This suggests that some factor in addition to or other than verotoxin may contribute to chronic infection. For example, even though both the EHEC serotypes 0157:H7 and O111:NM attach to and efface the microvilli of intestinal epithelia in gnotobiotic pigs, the O111:NM serotype causes more severe intestinal lesions and is more invasive and necrotizing than the 0157:H7 serotype (26b, 38) . Tissue destruction and invasiveness by the O111:NM organism might allow greater access of the verotoxin to lymphatic vessels and the systemic circulation, thereby affecting immune cells. This greater virulence and invasive capacity may contribute to the organism's ability to persistently infect its host. In addition, chronic inflammation seen with strain 10049 could cause the release of products such as tumor necrosis factor, while endotoxin levels may also contribute to the immunosuppression. Therefore, definitive incrimination of verotoxin as a contributor to an immunocompromised condition in the gnotobiotic pig model will require the creation of and challenge with a verotoxin-negative derivative of strain 10049.
